Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Clinical Rheumatology
Published in: Clinical Rheumatology 5/2015

01-05-2015 | Review Article

e-Rheumatology: are we ready?

Author: Yasser El Miedany

Published in: Clinical Rheumatology | Issue 5/2015

Login to get access

Abstract

Advances in technology led to a heightened interest in exploring the use of this technology in the standard rheumatology practice. Tech-Talks will enable the information at the patients’ and rheumatologists’ fingertips. As e-rheumatology is an idea whose time has come, this review outlines the e-health’s developments and its impact on both the patients and the treating rheumatologists. Also it will discuss the strengths and weaknesses of using apps and mobile health in the day-to-day rheumatology service as well as the ethical and financial aspects of this model of care.
Literature
1.
National Collaborating Centre for Chronic Conditions (2009) Rheumatoid arthritis: national clinical guideline for management and treatment in adults. Royal College of Physicians, London
2.
Palmer D, El Miedany Y (2012) PROMs: a novel approach to arthritis self-management. Br J Nurs 21(10):601–605CrossRefPubMed
3.
Palmer D, El Miedany Y (2010) EROMIA in inflammatory arthritis: the next step in standard practice. Br J Nurs 19(1):42–46CrossRefPubMed
4.
El Miedany Y, El Gaafary M, El Arousy N et al (2012) Arthritis education: the integration of patient-reported outcome measures and patient self-management. Clin Exp Rheumatol 30(6):899–904PubMed
5.
Stoffer M, Smolen J, Woolf A et al (2014) Development of patient-centred standards of care for rheumatoid arthritis in Europe: the eumusc.net project. Ann Rheum Dis 73(5):902–905CrossRefPubMedCentralPubMed
6.
El Miedany Y, El Gaafary M, Palmer D (2012) Assessment of the utility of visual feedback in the treatment of early rheumatoid arthritis patients: a pilot study. Rheumatol Int 32(10):3061–3068
7.
8.
9.
10.
Berland GK, Elliott MN, Morales LS et al (2001) Health information on the Internet: accessibility, quality, and readability in English and Spanish. JAMA 285(20):2612–2621CrossRefPubMedCentralPubMed
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
Grossman JM, Gerland A, Reed MC, Fahlman C (2007) Physicians’ experiences using commercial e-prescribing systems. Health Aff 26(3):393–404CrossRef
25.
26.
27.
Riley WT, Rivera DE, Atienza AA et al (2011) Health behaviour models in the age of mobile interventions: are our theories up to the task? Transl Behav Med 1(1):53–71CrossRefPubMedCentralPubMed
28.
Glynn LG, Murphy AW, Smith SM, Schroeder K, Fahey T (2010) Interventions used to improve control of blood pressure in patients with hypertension. Cochrane Database Syst Rev 3, CD005182PubMed
29.
Friedman RH, Kazis LE, Jette A et al (1996) A telecommunications system for monitoring and counseling patients with hypertension. Impact on medication adherence and blood pressure control. Am J Hypertens 9:285–292CrossRefPubMed
30.
Piette JD, Weinberger M, Kraemer FB, McPhee SJ (2001) Impact of automated calls with nurse follow-up on diabetes treatment outcomes in a Department of Veterans Affairs Health Care System: a randomized controlled trial. Diabetes Care 24(2):202–208CrossRefPubMed
31.
32.
Cook R, Topol E (2014) How digital medicine will soon save your life. Wall Str J
33.
34.
Lewtas J (2001) Telemedicine in rheumatology. J Rheumatol 28(8):1745PubMed
35.
Davis P, Howard R, Brockway P (2001) An evaluation of telehealth in the provision of rheumatologic consults to a remote area. J Rheumatol 28:1910–1913PubMed
36.
Leggett P, Graham L, Steele K et al (2001) Telerheumatology—diagnostic accuracy and acceptability to patient, specialist, and general practitioner. Br J Gen Pract 51(470):746–748PubMedCentralPubMed
37.
Albert DA, Merrihew K, Mecchella, et al (2014) Tele-rheumatology: despite improved access could there be a potential delay in care without a skilled “presenter”? Arthritis Rheumatol 66(11) Supplement Abstract 2311
Metadata
Title
e-Rheumatology: are we ready?
Author
Yasser El Miedany
Publication date
01-05-2015
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 5/2015
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-015-2897-y

Other articles of this Issue 5/2015

Clinical Rheumatology 5/2015 Go to the issue

Original Article

Wolf—living with SLE in a novel

Case Based Review

Anakinra treatment in patients with gout and type 2 diabetes

Original Article

Basophil count, a marker for disease activity in systemic lupus erythematosus

Review Article

Idiopathic inflammatory myopathies—a review

Original Article

Predictive factors for low rate of remission in a population of Colombian patients with severe proliferative lupus nephritis

Original Article

A prospective study of perceived injustice in whiplash victims and its relationship to recovery
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits